11.08.2017 Views

Innovation

Global Investor Focus, 02/2007 Credit Suisse

Global Investor Focus, 02/2007
Credit Suisse

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

GLOBAL INVESTOR FOCUS <strong>Innovation</strong> — 25<br />

A new way of<br />

thinking<br />

<strong>Innovation</strong> passes not only from rich societies and their multinationals to emerging economies.<br />

Ingenious ways of thinking and doing business are increasingly flowing the other way too.<br />

This reflects a wider, global trend of greater customer influence on corporate behavior.<br />

The mass-market model that fails to differentiate between individuals is past. In developing<br />

economies, this means understanding awareness, access, affordability and availability<br />

from the perspective of the poor.<br />

C. K. Prahalad, Professor of Corporate Strategy, University of Michigan<br />

<strong>Innovation</strong> lies at the heart of value creation. The process, focus<br />

and sources of innovation and value creation are changing. We<br />

need to focus on the key drivers of innovation. I think of the emergence<br />

of a new innovation and value creation model based upon<br />

three fundamental drivers:<br />

1. The role of the firm and the consumer is changing dramatically.<br />

This is the substance of my co-authored book “The Future of<br />

Competition: Co-Creating Unique Value with Customers.” We have<br />

long assumed the firm will always dominate the consumer because<br />

it has more information and more resources. But what we are beginning<br />

to see is that the consumer has as much access to information<br />

as the firm. Moreover, consumers are connected. Over<br />

three billion people will be connected by cell phones and PCs. They<br />

form communities based on specific interests. We must therefore<br />

make a transition to a competitive landscape where the firm no<br />

longer necessarily dominates the consumer, and where the consumer<br />

can actually affect the firm. That is true whether we look at<br />

Google or eBay or Starbucks – we can see a wide variety of businesses<br />

in which the influence of consumer communities is quite<br />

significant in terms of product development, pricing, distribution,<br />

and a host of other key aspects impacting the economics of the<br />

business.<br />

2. The interplay between the world’s rich and poor is fundamentally<br />

changing. We have always assumed the rich will dominate<br />

the poor. But what if the poor – five billion of them – started having<br />

influence on the rich? This is the thesis of my book, “Fortune at the<br />

Bottom of the Pyramid.” The evidence is now overwhelming. India<br />

alone is adding six million new wireless subscribers per month. Can<br />

Motorola, Nokia or Samsung really afford not to be there? And do<br />

they have to build new business models to serve those markets?<br />

For some of the world’s biggest firms, this has become a key issue.<br />

If India and China together have 500 –700 million subscribers, they<br />

will have considerable influence, even in setting standards and developing<br />

next-generation applications.<br />

3. <strong>Innovation</strong>s from the developing world are becoming critical<br />

to the developed world. We have always assumed that richer nations<br />

would dictate policies and conditions to emerging ones, but<br />

that is changing. For example, several years ago, no one would<br />

have predicted that the outsourcing of technology services to the<br />

developing world would influence how large companies are run.<br />

Today, IT and IT-enabled services are provided by outsourced<br />

operations in India and the Philippines, or increasingly in China and<br />

Poland. The question poses itself: is outsourcing just cost arbitrage,<br />

or is it increasingly innovation arbitrage? Outsourcing is<br />

increasingly cost-plus-innovation arbitrage. This trend is not confined<br />

to the IT industry. The same trend is visible in the pharmaceutical<br />

industry, where generics were seen as lowly imitators, and<br />

not a strategic concern for the large pharma companies like Pfizer,<br />

Novartis, Merck and GlaxoSmithKline. But because of the level of<br />

sophistication reached in reverse engineering and doing things at<br />

such low cost, Indian pharma efforts are becoming critical for established<br />

Western pharma firms. Is this trend just confined to the<br />

outsourcing of manufacturing? Or just to those drugs that are coming<br />

off patent? Or is this a precursor to a revolution – a new way

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!